Lista de obras - Anna Sokolenko - Dominio Público Uruguay

ATM mutation spectrum in Russian children with ataxia-telangiectasia

artículo científico publicado en 2019

BRCA1 4153delA founder mutation in Russian ovarian cancer patients

artículo científico publicado en 2006

BRCA1-associated and sporadic ovarian carcinomas: outcomes of primary cytoreductive surgery or neoadjuvant chemotherapy

artículo científico publicado en 2019

BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine

artículo científico publicado en 2016

Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers.

artículo científico publicado en 2014

CHEK2 1100delC mutation is frequent among Russian breast cancer patients.

artículo científico publicado en 2006

CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors

artículo científico publicado en 2006

CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity

artículo científico publicado en 2004

Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients

artículo científico publicado en 2015

Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan

scientific article published on 01 December 2016

Detection of BRCA1 gross rearrangements by droplet digital PCR.

artículo científico publicado en 2017

Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.

artículo científico publicado en 2014

Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations

artículo científico publicado en 2014

EGFR T790M Mutation in TKI-Naïve Clinical Samples: Frequency, Tissue Mosaicism, Predictive Value and Awareness on Artifacts

scientific article published on 27 August 2018

Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer

scientific article published on 01 October 2018

Evidence for a pathogenic role of BRCA1 L1705P and W1837X germ-line mutations.

artículo científico publicado en 2016

Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence.

artículo científico publicado en 2013

Exome Sequencing of a Family with Bardet-Biedl Syndrome Identifies the Common Russian Mutation c.1967_1968delTAinsC in BBS7.

artículo científico publicado en 2015

Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls

artículo científico publicado en 2009

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

artículo científico publicado en 2018

Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia

artículo científico publicado en 2007

Frequency and molecular characteristics of PALB2-associated cancers in Russian patients

scientific article published on 30 September 2020

Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients

scientific article published on 09 August 2020

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

artículo científico publicado en 2013

Hereditary breast-ovarian cancer syndrome in Russia.

artículo científico publicado en 2010

High efficacy of cisplatin neoadjuvant therapy in a prospective series of patients carrying BRCA1 germ-line mutation.

artículo científico publicado en 2015

High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.

artículo científico publicado en 2006

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients

artículo científico publicado en 2009

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia

artículo científico publicado en 2011

High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.

artículo científico publicado en 2014

High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation

artículo científico publicado en 2015

High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases.

artículo científico publicado en 2010

Identification of novel hereditary cancer genes by whole exome sequencing

artículo científico publicado en 2015

Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing

artículo científico publicado en 2009

Mitomycin C plus cisplatin for systemic treatment of recurrent BRCA1-associated ovarian cancer

artículo científico publicado en 2020

Mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast in BRCA1 carrier

artículo científico publicado en 2009

Molecular Diagnostics in Clinical Oncology

artículo científico publicado en 2018

Molecular profiles of BRCA1-associated ovarian cancer treated by platinum-based therapy: Analysis of primary, residual and relapsed tumors

scientific article published on 29 November 2019

Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders.

artículo científico publicado en 2018

Multigene testing for breast cancer risk assessment: an illusion of added clinical value

artículo científico publicado en 2017

NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.

artículo científico publicado en 2005

Non-founder BRCA1 mutations in Russian breast cancer patients

artículo científico publicado en 2010

Novel ALK fusion partners in lung cancer

artículo científico publicado en 2015

Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes

artículo científico publicado en 2008

PALB2 mutations in German and Russian patients with bilateral breast cancer

artículo científico publicado en 2010

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

artículo científico publicado en 2011

Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis

artículo científico publicado en 2018

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

artículo científico publicado en 2015

Principles of clinical management of ovarian cancer

scientific article published on 01 December 2018

Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.

artículo científico publicado en 2017

Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers

artículo científico publicado en 2019

Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies

artículo científico publicado en 2018

The effects of Celebrex on mammary tumorigenesis and aging in HER2/neu transgenic mice

artículo científico publicado en 2009

Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation

scientific article published on 01 March 2013

Lista de obras de Anna Sokolenko

ATM mutation spectrum in Russian children with ataxia-telangiectasia

BRCA1 4153delA founder mutation in Russian ovarian cancer patients

BRCA1-associated and sporadic ovarian carcinomas: outcomes of primary cytoreductive surgery or neoadjuvant chemotherapy

BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine

Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers.

CHEK2 1100delC mutation is frequent among Russian breast cancer patients.

CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors

CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity

Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients

Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan

Detection of BRCA1 gross rearrangements by droplet digital PCR.

Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele.

Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations

EGFR T790M Mutation in TKI-Naïve Clinical Samples: Frequency, Tissue Mosaicism, Predictive Value and Awareness on Artifacts

Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer

Evidence for a pathogenic role of BRCA1 L1705P and W1837X germ-line mutations.

Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence.

Exome Sequencing of a Family with Bardet-Biedl Syndrome Identifies the Common Russian Mutation c.1967_1968delTAinsC in BBS7.

Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia

Frequency and molecular characteristics of PALB2-associated cancers in Russian patients

Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Hereditary breast-ovarian cancer syndrome in Russia.

High efficacy of cisplatin neoadjuvant therapy in a prospective series of patients carrying BRCA1 germ-line mutation.

High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia

High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.

High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation

High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases.

Identification of novel hereditary cancer genes by whole exome sequencing

Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing

Mitomycin C plus cisplatin for systemic treatment of recurrent BRCA1-associated ovarian cancer

Mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast in BRCA1 carrier

Molecular Diagnostics in Clinical Oncology

Molecular profiles of BRCA1-associated ovarian cancer treated by platinum-based therapy: Analysis of primary, residual and relapsed tumors

Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders.

Multigene testing for breast cancer risk assessment: an illusion of added clinical value

NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.

Non-founder BRCA1 mutations in Russian breast cancer patients

Novel ALK fusion partners in lung cancer

Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes

PALB2 mutations in German and Russian patients with bilateral breast cancer

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis

Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe

Principles of clinical management of ovarian cancer

Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.

Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers

Spectrum of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies

The effects of Celebrex on mammary tumorigenesis and aging in HER2/neu transgenic mice

Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation